Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schug

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Oncogene|November 19, 2020
BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitorsAnna Han, Timothy J Purwin, Nelisa Bechtel, et al.
Annals of the New York Academy of Sciences|January 3, 2013
Fetal programming and environmental exposures: implications for prenatal care and preterm birthThaddeus T Schug, Adrian Erlebacher, Sarah Leibowitz, et al.
Oncogene|January 20, 2022
Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanomaAnna Han, Vivian Chua, Usman Baqai, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 11, 2013
A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research programThaddeus T Schug, Jerrold J Heindel, Luísa Camacho, et al.
Molecular and Cellular Biology|September 18, 2013
SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidationGaëlle Laurent, Vincent C J de Boer, Lydia W S Finley, et al.
Cell Reports|January 19, 2017
Acetate Recapturing by Nuclear Acetyl-CoA Synthetase 2 Prevents Loss of Histone Acetylation during Oxygen and Serum LimitationVinay Bulusu, Sergey Tumanov, Evdokia Michalopoulou, et al.
Cell Reports|November 23, 2024
ACSS1-dependent acetate utilization rewires mitochondrial metabolism to support AML and melanoma tumor growth and metastasisSabina I Hlavaty, Kelsey N Salcido, Katherine A Pniewski, et al.
Molecular Cancer Therapeutics|November 28, 2018
3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism ModifiersDylan T Jones, Alessandro Valli, Syed Haider, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2016
Minireview: Endocrine Disruptors: Past Lessons and Future DirectionsThaddeus T Schug, Anne F Johnson, Linda S Birnbaum, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 7, 2017
Metabolic Syndrome and Associated Diseases: From the Bench to the ClinicDonna L Mendrick, Anna Mae Diehl, Lisa S Topor, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Oncogene|November 19, 2020
BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitorsAnna Han, Timothy J Purwin, Nelisa Bechtel, et al.
Annals of the New York Academy of Sciences|January 3, 2013
Fetal programming and environmental exposures: implications for prenatal care and preterm birthThaddeus T Schug, Adrian Erlebacher, Sarah Leibowitz, et al.
Oncogene|January 20, 2022
Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanomaAnna Han, Vivian Chua, Usman Baqai, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 11, 2013
A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research programThaddeus T Schug, Jerrold J Heindel, Luísa Camacho, et al.
Molecular and Cellular Biology|September 18, 2013
SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidationGaëlle Laurent, Vincent C J de Boer, Lydia W S Finley, et al.
Cell Reports|January 19, 2017
Acetate Recapturing by Nuclear Acetyl-CoA Synthetase 2 Prevents Loss of Histone Acetylation during Oxygen and Serum LimitationVinay Bulusu, Sergey Tumanov, Evdokia Michalopoulou, et al.
Cell Reports|November 23, 2024
ACSS1-dependent acetate utilization rewires mitochondrial metabolism to support AML and melanoma tumor growth and metastasisSabina I Hlavaty, Kelsey N Salcido, Katherine A Pniewski, et al.
Molecular Cancer Therapeutics|November 28, 2018
3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism ModifiersDylan T Jones, Alessandro Valli, Syed Haider, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2016
Minireview: Endocrine Disruptors: Past Lessons and Future DirectionsThaddeus T Schug, Anne F Johnson, Linda S Birnbaum, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 7, 2017
Metabolic Syndrome and Associated Diseases: From the Bench to the ClinicDonna L Mendrick, Anna Mae Diehl, Lisa S Topor, et al.
Pageof 8